Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

We offer a large selection of prebuilt CRISPR knock-in cell lines within the RAS-RAF pathway utilizing the HiBiT tag. Cell backgrounds including LgBiT allow live-cell kinetic analysis of the HiBiT-tagged protein.

Search list for your cell line of interest (e.g., KRAS(WT), RAF1)
Search Filter By
KI Cell Line Background
HiBiT-KRAS(G12C) MIA PaCa-2
HiBiT-KRAS(G12D) AsPc-1
HiBiT-KRAS(G12D) SW1990
HiBiT-KRAS(G12D) HEK293
HiBiT-KRAS(G12S) A549
HiBiT-KRAS(G12V) HEK293
HiBiT-KRAS(G12V) SW620
HiBiT-KRAS(G13D) NCI-H647
HiBiT-KRAS(WT) HEK293
HiBiT-KRAS(WT) NCl-H1299
HiBiT-NRAS(Q61R) SW1271
HiBiT-NRAS(WT) HEK293
HiBiT-ARAF A549
HiBiT-BRAF A549
HiBiT-BRAF(V600E) A375
RAF1-HiBiT A549
RAF1-HiBiT Hs766T
RAF1-HiBiT PANC 08.13

Would you like an offline copy of a table listing all CRISPR-tagged cell lines?

Download PDF

Ordering Options

Contact us to get started with the cell lines you need or to stay updated on our growing list of available knock-in cell lines.

If you do not see a form below, please turn off your ad blocker and refresh the page.

CRISPR Ready-to-Use Knock-in Reporter Cells - Inquiry
First Name*
 
 
 
 
Last Name*
 
 
 
 
Company/Institute*
 
 
 
 
State/Region*
 
 
 
 
Country - Full List*
 
 
 
 
Email*
 
 
 
 
Phone*
 
 
 
 
 
 
 
Communication Method*
 
Email
Phone
 
 
 
 
 
 
Enter your cell lines of interest*
 
 
 
 
  
 
 
I have read and agree to the Promega Guidelines for Processing Personal Information (see link below).*
 
 
 
 
I agree to receive e-mails about events, promotions, surveys, products and technologies.*
 
 
 
 
 
 
 
Overview
Protocols
Specifications
Resources
Related Products

HiBiT Knock-In Cell Lines for RAS Pathway Targets

CRISPR-engineered HiBiT Knock-in Cell Lines offer a powerful tool to study the abundance and degradation of endogenous proteins involved in critical signaling pathways, such as the RAS-RAF-MEK-ERK cascade. This pathway begins with the activation of RAS, a family of small GTPases, which includes KRAS, HRAS and NRAS. Active, GTP-bound RAS activates the RAF family of serine/threonine kinases (c-Raf, B-Raf, A-Raf). This activation sequence leads to the phosphorylation of MEK and ultimately ERK, which are essential for controlling various cellular processes.


An overview of the RAS-RAF-MEK-ERK pathway.

An overview of the RAS-RAF-MEK-ERK pathway.

HiBiT is a small, 11-amino-acid epitope tag that enables precise measurement of protein expression through bioluminescent signal when bound to its complementation partner, LgBiT. The bound complex exhibits high luciferase activity, producing a bright luminescent signal in the presence of added substrate. The small size of the HiBiT tag makes it ideal for endogenous tagging using CRISPR/Cas9 editing.

When inserted into key proteins within this pathway using CRISPR technology, the HiBiT tag enables precise monitoring of protein dynamics in real-time. Upon binding with LgBiT, the HiBiT tag generates a luminescent signal, which decreases as the tagged protein undergoes degradation. This method allows researchers to quantitatively assess protein degradation rates, Dmax and DC50 values, making it a powerful tool for studying protein stability and for high-throughput screening of compounds that influence the RAS-RAF-MEK-ERK signaling pathway.

A.

Scatter plots of live-cell luminescence of HiBiT-KRasG12C with an LC-2 inhibitor.

B.

Scatter plots of live-cell luminescence of HiBiT-KRasG12C with an MRTX849 inhibitor.

Live-cell-degradation kinetics of endogenous HiBiT-KRasG12C following PROTAC treatment. Panel A. HiBiT was inserted via CRISPR/Cas9 at the N-terminal endogenous KRasG12C loci in the MIA-PaCa2 cell line. Following LgBiT expression, dose-response kinetic degradation experiments were performed using the VHL-based KRasG12C PROTAC, LC-2, in CO2-independent medium containing Nano-Glo® Endurazine™ Substrate. Fractional RLU is plotted relative to the DMSO control. Panel B. Similar live-cell luminescent studies of HiBiT-KRasG12C in MIA-Paca2 cells using the parent inhibitor, MRTX849, which does not show loss of KRasG12C over the same dose-response treatments.

 

Interested in our other CRISPR knock-in cell lines? View our full library of ready-to-use cells.

Protocols

No protocols available

Specifications

Catalog Number: